MedPath
FDA Approval

Desferal

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
August 2, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Deferoxamine(500 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Desferal

Product Details

NDC Product Code
0078-0467
Application Number
NDA016267
Marketing Category
NDA (C73594)
Route of Administration
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Effective Date
September 9, 2022
Code: V9TKO7EO6KClass: ACTIBQuantity: 500 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath